TruthArchive.ai - Related Video Feed

Speaker 0 states that one of their three children experienced health issues, including heart inflammation, after receiving the vaccine and subsequently lost their job for refusing further vaccination. This adverse reaction is officially registered. The speaker recounts a doctor advising their son against further vaccination outside a hospital setting, but later denying having said so. Speaker 1 says there is a good system for reporting side effects in New Zealand and finds no clear evidence of suppression of medical side effects of the Pfizer vaccine. Speaker 0 questions why the vaccine is still in use given the side effects. Speaker 1 responds that society decided to tolerate a certain number of adverse effects for the greater good, characterizing the speaker's family member's reaction as "taking one for the team."

Speaker 0 asks if Moderna uses its profits to help people injured by their vaccine. Speaker 1 responds that indemnities are a government policy matter and cannot comment. Speaker 0 clarifies if Moderna is unwilling to take responsibility for the safety of their vaccine. Speaker 1 emphasizes their commitment to vaccine safety but reiterates that indemnities are a matter for policymakers. Speaker 0 questions the moral obligation of Moderna to assist vaccine victims, but Speaker 1 does not provide a direct answer. The conversation ends with Speaker 0 assuming the answer is zero and thanking them.

The FDA has approved a new mRNA Moderna vaccine, despite known serious adverse events. The speaker expresses disappointment, suggesting the FDA is slow to change course. The approval letter concerns the speaker. The vaccine, MN spike, is an mRNA vaccine that produces spike protein, with lipid nanoparticles that will go everywhere. The manufacturer's data indicates serious adverse events were reported by 2.7% of participants receiving the new vaccine, compared to 2.6% for the older vaccine it replaces. The speaker finds it bemusing that a treatment with a 2.7% risk of serious adverse events would be authorized, unless there was a significant risk-benefit. The new vaccine (mRNA 1283) was compared to the old Moderna vaccine (mRNA 1273), not a placebo.

Speaker 0 is pleased about vaccination effectiveness in preventing severe COVID and long-term effects. They mention rare side effects from vaccines and emphasize the importance of ongoing monitoring. Speaker 1 questions the safety of products on the market without complete testing. The TGA lacks data on adverse events due to underreporting, leading to audience frustration.

The discussion revolves around the lack of complete safety study information in the patient package insert for the Moderna vaccine. The speaker acknowledges the missing data but assures safety based on personal experience. When asked about the specific studies supporting the vaccine's safety and effectiveness, the speaker admits to not having an answer. The conversation ends with the speaker feeling inadequate for not being able to provide more information.

A person asks a pharmacy employee for the Moderna vaccine safety studies and placebo safety studies. The employee provides the manufacturer's package insert, stating the patient version is truncated, but the full information is inside. The person questions how informed consent is possible if all safety studies aren't listed. The employee agrees, stating they should not be giving the vaccines at all, but are told to. The employee claims everything they have seen, including patients they have given it to, indicates it is safe. When asked about the studies supporting the claim of safety and effectiveness, the employee says they cannot answer.

Speaker 0 asks if Moderna puts any of its profits into helping people injured by the vaccine. Speaker 1 states that indemnities are a matter for the government and cannot comment further. Speaker 0 questions if Moderna is unwilling to underwrite the risk of its own vaccine and prioritize its safety. Speaker 1 reiterates that they take vaccine safety seriously and have a good pharmacovigilance process in place, but indemnities are a matter for policymakers. Speaker 0 asks about the moral responsibility of helping vaccine victims, to which Speaker 1 does not provide a direct answer. The conversation ends with Speaker 0 assuming the answer is zero.

Speaker 0 confronts a pharmacist about their son's hospitalization due to myocarditis after receiving a COVID jab. Speaker 0 is upset that his wife was not informed about this potential side effect. Speaker 1 explains that they may not disclose the side effect to avoid scaring parents away from vaccinating their children. Speaker 0 expresses disbelief and insists that parents should be given accurate information to make informed decisions.

Speaker 0 acknowledges reports of myocarditis and pericarditis associated with the Pfizer vaccine but seems unsure about the mechanism behind it. Speaker 1 asks if the vaccine was tested for its ability to stop virus transmission before being released. Speaker 2 questions if people were forced to get vaccinated to keep their jobs and asks Speaker 0 to retract their statement. Speaker 0 clarifies that everyone had the choice to get vaccinated or not, and they don't believe anyone was forced.

The speaker discusses the vaccine's link to death and disability, citing over 37,000 deaths globally reported on VAERS. They criticize regulators for not addressing this issue earlier and mention a conversation with Francis Collins about vaccine-related deaths. The speaker also mentions a conversation with Dr. Redfield, who admitted downplaying vaccine injuries to avoid creating hesitancy. Dr. Redfield acknowledged that there are more injuries than reported.

COVID vaccines are declared safe by Speaker 0. Speaker 1 expresses pain, trauma, and regret due to lack of help for vaccine injuries. They mention people with amputations and heart conditions, and question why they had to set up a support group in Scotland. They criticize the vaccine damage payment scheme and state that over 30,000 people in Scotland have had adverse reactions to the vaccine. Speaker 1 demands that Rashid Shunaka start doing the right thing. Speaker 0 responds by saying that decisions regarding the vaccine were made based on medical advice from experts.

The speaker expresses concern that only 5% of adverse reactions are reported in the database, suggesting it's just the tip of the iceberg. Another speaker reassures that the vaccine is safe and there is no evidence of it causing deaths. Prior to the COVID vaccine rollout, an average of 1500 adverse event reports were received annually for all vaccines in New Zealand, resulting in one or fewer reported deaths per year.

The speaker discusses the safety data of Pfizer's vaccine trials, highlighting the short duration of the trials and the potential for serious adverse events. They mention a 1 in 800 rate of serious harm per shot and express concern about the long-term effects and mortality risk. They mention an estimate of 17 million global deaths from the vaccine and compare it to the death toll of a global war. The speaker emphasizes the seriousness of the situation.

Speaker 0 explains that each brand of vaccine is different, including Moderna. Speaker 1 asks if they can see the safety studies for all the vaccines, but Speaker 0 says the information given to patients does not contain that. Speaker 1 asks which vaccine they are giving, and Speaker 0 confirms it is the one they are giving. Speaker 1 questions why the package insert is intentionally blank, and Speaker 0 says the safety studies are inside. Speaker 1 asks how this is informed consent, and Speaker 0 suggests talking to CVS. Speaker 1 expresses concern about not knowing what they are injecting, and Speaker 0 agrees it is a valid point. Speaker 0 admits they cannot answer which studies prove the vaccine is safe and effective.

Speaker 0 asks Speaker 1 to explain why the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination but does not provide a clear explanation. Speaker 0 insists on understanding the mechanism and questions why the vaccine is considered safe without addressing the risks. Speaker 2 intervenes, suggesting that Speaker 1 will address the question later. Speaker 1 talks about the benefit-risk ratio and the global recommendation of health authorities. Speaker 0 reiterates the question, to which Speaker 1 agrees to provide a response later. Speaker 2 confirms this agreement.

The speaker questions how many people injected with mRNA products knew they weren't receiving a traditional vaccine, suggesting many, including medical professionals, are unaware due to the perception of conspiracy. The speaker claims there was a sufficient safety signal in VAERS to halt the rollout in January, citing almost 90,000 VAERS entries and nearly 700 deaths within the first month. They state that historically, products causing over 50 deaths have been pulled from the market. The speaker questions why the CDC, HHS, and FDA aren't investigating this data.

Speaker 0 asked about the visibility of the medium to long-term effects of the vaccine in three to five years. Speaker 1 responded that they cannot predict how things will be in three to five years, but mentioned that 92-93% of the population will be vaccinated. Speaker 0 expressed confusion, and Speaker 1 clarified that 92-93% is the current vaccination rate. Speaker 0 raised concerns about potential side effects, but Speaker 1 reassured them that if there are any, the majority of the population would be affected. Speaker 0 remained unconvinced and expressed hesitation about getting vaccinated.

They received texts claiming extraordinary lives, but the speaker asks how many people have suffered long-term health consequences from the vaccine. The other person, Helen, responds that there have been 10 cases of long-term consequences. In March 2023, MedSafe received 11,289 reports, with 1,062 listed as disabled, 118 as life-threatening, and 184 as deaths. The speaker clarifies if it's 100 or 1,000 cases, but Helen confirms it's around 10 for long-term effects.

The speaker asks Pfizer and Moderna to explain how the COVID-19 vaccine causes myocarditis. The response from the doctors is that the exact mechanism is still being studied, but myocarditis is generally an autoimmune response that can occur after COVID-19 or other infections. The speaker questions if other organs could also be affected by the vaccine, but the doctors explain that ongoing surveillance is in place to monitor potential risks. The speaker expresses concern about the lack of initial disclosure of these risks. The doctors emphasize the importance of preventing COVID-19 and state that the reported rate of myocarditis is around 2-3 per 100,000 doses. The speaker argues that if it can happen to the heart, it could happen to other organs. The conversation ends due to time constraints.

Speaker 0 asks if people are not afraid of the side effects of the Covid vaccine. Speaker 1 responds that they are more afraid of long-term effects of Covid itself than the vaccine's side effects. They mention that billions of people have been vaccinated with no major side effects reported. Speaker 1 also addresses the concern that women are more affected by vaccine side effects, stating that there is no scientific evidence to support this claim. They mention not having any information from the COVAS (the organization responsible for scientific surveillance) or any published studies on this matter.

Speaker 0 questions Speaker 1 about the lack of clinical trial data for the MMR vaccine. Speaker 1 insists that the vaccine was extensively tested before being licensed and that millions of doses have been used. Speaker 0 asks for proof of pre-licensure clinical trials, but Speaker 1 only refers to a book and mentions studies done in the 1960s. Speaker 0 argues that the data provided is not sufficient and questions the absence of a placebo group. Speaker 1 admits uncertainty about the inclusion of control groups but maintains that safety assessments were conducted. Speaker 0 concludes that no randomized placebo-controlled study exists for the MMR vaccine. Speaker 1 agrees to provide additional information after the deposition.

The speaker questions the source of the claim that 20 million lives have been saved. They ask for data and studies to support this number. The response is indirect and the meeting is about to end when the speaker jumps back in to clarify that the 20 million lives saved refers to all vaccines, not just mRNA vaccines. The speaker is unable to ask for further clarification. They find it suspicious that this number is being thrown around without proper explanation. They suggest that these numbers are made up.

Speaker 0 asks Speaker 1 to explain the process of how the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination. Speaker 0 insists on an explanation of the mechanism, but Speaker 1 does not provide a direct answer. Speaker 1 emphasizes that all medicines have benefits and side effects and refers to the benefit-risk ratio. Speaker 0 continues to press for an explanation of the biochemical pathway, but Speaker 1 agrees to provide a response later. The transcript ends with Speaker 2 confirming Speaker 1's agreement to give a further response.

Speaker 0 assures that reported side effects of the vaccine are expected and not concerning. They urge people to report any unusual reactions. Speaker 1 emphasizes the importance of transparency and unbiased investigation into outbreaks following vaccination. They question the accuracy of recording underlying causes of death related to COVID-19. Speaker 0 dismisses these concerns, stating that spreading doubts about vaccine safety during a pandemic is dangerous and undermines public health. Speaker 1 finds the minister's response concerning and ends the conversation.

The speakers express concern about the limited reporting of adverse reactions to vaccines. They mention a report suggesting that only 5% of adverse reactions are recorded in the database. Despite this, they assure viewers that the COVID vaccine is safe. They highlight that prior to the COVID vaccine rollout, the average number of adverse event reports for all vaccines in New Zealand was 1500 per year, with one or fewer deaths reported annually.